TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) Investor Investigation Over Potential Breaches Of Fiduciary Duties Announced

  • If you are a current long-term stockholder of shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

August 27, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) was announced concerning whether certain ImmunoCellular Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: